Acquisition announcement
Intersurgical® announces acquisition of the Acute Care and Interventional Urology businesses of Teleflex®
Strategic acquisition expands Intersurgical's product portfolio and strengthens its offerings
Wokingham, December 9th, 2025 – Intersurgical®, a global leader in the design, manufacture and supply of high-quality medical devices for anaesthesia and respiratory care, today announced that it has entered into an agreement to acquire the Acute Care and Interventional Urology businesses of Teleflex®, a strategic milestone that reinforces Intersurgical’s long-term growth strategy.
With this transaction, Intersurgical® will integrate the Acute Care and Interventional Urology product ranges, technical expertise, and operations, enabling the Company to deliver a broader, more comprehensive portfolio to its customers and distribution partners worldwide.
“This acquisition reflects a long-term ambition to expand our range and offering to the market. We are excited to bring the Teleflex® Acute Care and Interventional Urology teams into our family. We have long considered their brands to be world class and synergistic with the Intersurgical® range,” said Charles Bellm, Managing Director and CEO, Intersurgical®. “Teleflex® has built a strong reputation over many years in these two categories supported by valuable product range depth, excellent people and technical knowledge. Combined, we are better positioned to serve our customers with an expanded portfolio and increased operational capacity.”
Key Benefits of the Acquisition Post-Closing
- Expanded Product Portfolio: Customers will gain access to a broader suite of solutions across anaesthesia, airway management and urology.
- Commitment to Continuity: Intersurgical® will maintain existing processes, customer support channels, and points of contact to ensure a seamless transition.
- Enhanced Capabilities: The integration will strengthen research, development, and technical support resources, enabling more robust service and long-term growth.
Teleflex® Acute Care and Interventional Urology operations will continue under the leadership of Intersurgical®, with both organisations working collaboratively to ensure alignment and operational efficiency.
“We look forward to welcoming the teams from these businesses of Teleflex® and building on the strong foundations and reputable portfolio they have established,” continued Bellm. “This is an exciting step forward that will create meaningful value for our customers, employees, and partners.”
“For the Acute Care team, this transaction will provide a strong and stable path for continued progress” said Kevin Robinson, President and General Manager, Acute Care. “Our products and people have earned the trust of clinicians around the world, and this acquisition will allow us to build on that foundation. Intersurgical’s commitment to operational excellence, customer support, and long-term investment aligns closely with how we work. This transition will strengthen our ability to serve customers, advance our portfolio, and support better outcomes for patients.”
“This transaction marks an exciting new chapter for our Interventional Urology team” said Travis Gay, President and General Manager, Interventional Urology. “Our portfolio, clinical expertise, and strong customer partnerships have been built over many years, and this transition gives the business a solid platform for future growth. Intersurgical® shares our focus on product quality, innovation, and supporting providers with solutions that make a meaningful difference in patient care. Together, we can expand our reach and bring even greater value to the urology community.”
The transaction is expected to be completed in the second half of 2026, subject to customary regulatory approvals and closing conditions.
Media enquiries: communications@intersurgical.com